• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定μ-阿片受体短期同源脱敏所需的两个C末端氨基酸,即丝氨酸(355)和苏氨酸(357)。

Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors.

作者信息

Wang Hung-Li, Chang Wen-Teng, Hsu Chia-Yu, Huang Pei-Chen, Chow Yu-Wen, Li Allen H

机构信息

Department of Physiology, Chang Gung University School of Medicine, Tao-Yuan, Taiwan, ROC.

出版信息

Biochem Pharmacol. 2002 Jul 15;64(2):257-66. doi: 10.1016/s0006-2952(02)01114-0.

DOI:10.1016/s0006-2952(02)01114-0
PMID:12123746
Abstract

Our recent study suggests that a cluster of Ser/Thr residues (T(354)S(355)S(356)T(357)) at the intracellular carboxyl tail of rat mu-opioid receptor (MOR1) is required for the development of short-term homologous desensitization. To investigate the functional role played by individual serine or threonine residue of this (TSST) cluster in the agonist-induced mu-opioid receptor desensitization, point mutant (T354A), (S355A), (S356A) and (T357A) mu-opioid receptors were prepared and stably expressed in human embryonic kidney 293 cells (HEK 293 cells). Similar to wild-type mu-opioid receptors, mutant (T354A) and (S356A) mu-opioid receptors stably expressed in HEK 293 cells developed homologous desensitization after 30 min pretreatment of DAMGO ([D-Ala(2),N-methyl-Phe(4),Gly-ol(5)]enkephalin), a specific mu-opioid receptor agonist. Substituting Ser(355)or Thr(357) with alanine resulted in a significant attenuation of agonist-induced mu-opioid receptor desensitization. In HEK 293 cells stably expressing double mutant (S355A/T357A) mu-opioid receptors, DAMGO pretreatment failed to significantly affect the efficacy and potency by which DAMGO inhibits forskolin-stimulated adenylyl cyclase activity. Consistent with the general belief that agonist-induced phosphorylation of guanine nucleotide binding protein (G protein)-coupled receptors is involved in homologous desensitization. Treating HEK 293 cells expressing wild-type mu-opioid receptors with 5 microM DAMGO for 30 min induced the receptor phosphorylation. Mutation of Ser(355) and Thr(357) also greatly impaired DAMGO-induced mu-opioid receptor phosphorylation. These results suggest that two C-terminal amino acids, Ser(355) and Thr(357), are required for short-term homologous desensitization and agonist-induced phosphorylation of mu-opioid receptors expressed in HEK 293 cells.

摘要

我们最近的研究表明,大鼠μ-阿片受体(MOR1)细胞内羧基末端的一组丝氨酸/苏氨酸残基(T(354)S(355)S(356)T(357))是短期同源脱敏发展所必需的。为了研究该(TSST)簇中单个丝氨酸或苏氨酸残基在激动剂诱导的μ-阿片受体脱敏中所起的功能作用,制备了点突变体(T354A)、(S355A)、(S356A)和(T357A)μ-阿片受体,并在人胚肾293细胞(HEK 293细胞)中稳定表达。与野生型μ-阿片受体相似,在HEK 293细胞中稳定表达的突变体(T354A)和(S356A)μ-阿片受体在特异性μ-阿片受体激动剂DAMGO([D-丙氨酸(2),N-甲基苯丙氨酸(4),甘氨醇(5)]脑啡肽)预处理30分钟后出现同源脱敏。用丙氨酸替代丝氨酸(355)或苏氨酸(357)会导致激动剂诱导的μ-阿片受体脱敏显著减弱。在稳定表达双突变体(S355A/T357A)μ-阿片受体的HEK 293细胞中,DAMGO预处理未能显著影响DAMGO抑制福斯高林刺激的腺苷酸环化酶活性的效力和效能。与普遍观点一致,即激动剂诱导的鸟嘌呤核苷酸结合蛋白(G蛋白)偶联受体的磷酸化参与同源脱敏。用5微摩尔/升DAMGO处理表达野生型μ-阿片受体的HEK 293细胞30分钟可诱导受体磷酸化。丝氨酸(355)和苏氨酸(357)的突变也极大地损害了DAMGO诱导的μ-阿片受体磷酸化。这些结果表明,两个C末端氨基酸,丝氨酸(355)和苏氨酸(357),是HEK 293细胞中表达的μ-阿片受体短期同源脱敏和激动剂诱导的磷酸化所必需的。

相似文献

1
Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors.鉴定μ-阿片受体短期同源脱敏所需的两个C末端氨基酸,即丝氨酸(355)和苏氨酸(357)。
Biochem Pharmacol. 2002 Jul 15;64(2):257-66. doi: 10.1016/s0006-2952(02)01114-0.
2
A cluster of Ser/Thr residues at the C-terminus of mu-opioid receptor is required for G protein-coupled receptor kinase 2-mediated desensitization.μ-阿片受体C末端的一组丝氨酸/苏氨酸残基是G蛋白偶联受体激酶2介导的脱敏所必需的。
Neuropharmacology. 2000 Jan 28;39(3):353-63. doi: 10.1016/s0028-3908(99)00174-4.
3
Two C-terminal amino acids, Ser(334) and Ser(335), are required for homologous desensitization and agonist-induced phosphorylation of opioid receptor-like 1 receptors.阿片样物质受体样1受体的同源脱敏和激动剂诱导的磷酸化需要两个C末端氨基酸,即丝氨酸(334)和丝氨酸(335)。
Cell Signal. 2006 May;18(5):670-8. doi: 10.1016/j.cellsig.2005.06.009. Epub 2005 Jul 14.
4
Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization.羧基末端内的丝氨酸363、苏氨酸370和丝氨酸375残基的磷酸化对μ-阿片受体的内化有不同的调节作用。
J Biol Chem. 2001 Apr 20;276(16):12774-80. doi: 10.1074/jbc.M009571200. Epub 2001 Jan 25.
5
A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation.μ-阿片受体细胞内第三段远端环中的一个保守精氨酸是G蛋白激活所必需的。
J Neurochem. 1999 Mar;72(3):1307-14. doi: 10.1046/j.1471-4159.1999.0721307.x.
6
Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells.丝裂原活化蛋白激酶参与激动剂诱导的HEK 293细胞中μ-阿片受体的磷酸化。
J Neurochem. 2000 Jan;74(1):414-22. doi: 10.1046/j.1471-4159.2000.0740414.x.
7
Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.孤啡肽/痛敏肽增强[D-丙氨酸2,N-甲基苯丙氨酸4,甘氨酸5-醇]-脑啡肽诱导的μ-阿片受体磷酸化。
Mol Pharmacol. 2005 Aug;68(2):447-56. doi: 10.1124/mol.105.011536. Epub 2005 May 12.
8
Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.人胚肾293细胞中μ-阿片受体脱敏的激动剂选择性机制
Mol Pharmacol. 2006 Aug;70(2):676-85. doi: 10.1124/mol.106.022376. Epub 2006 May 8.
9
Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor.将苏氨酸394替换为丙氨酸可促进大鼠μ阿片受体的内化和再敏化。
Mol Pharmacol. 1999 Feb;55(2):263-8. doi: 10.1124/mol.55.2.263.
10
Receptor density and recycling affect the rate of agonist-induced desensitization of mu-opioid receptor.受体密度和再循环影响阿片μ受体激动剂诱导的脱敏速率。
Mol Pharmacol. 2000 Aug;58(2):388-98. doi: 10.1124/mol.58.2.388.

引用本文的文献

1
Post-translational Modifications of Opioid Receptors.阿片受体的翻译后修饰。
Trends Neurosci. 2020 Jun;43(6):417-432. doi: 10.1016/j.tins.2020.03.011. Epub 2020 Apr 16.
2
Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs.慢性吗啡处理破坏 GPCR 激酶依赖的快速脱敏。
Mol Pharmacol. 2020 Oct;98(4):497-507. doi: 10.1124/mol.119.119362. Epub 2020 May 3.
3
Recent Progress in Opioid Research from an Electrophysiological Perspective.从电生理学角度看阿片类药物研究的最新进展。
Mol Pharmacol. 2020 Oct;98(4):401-409. doi: 10.1124/mol.119.119040. Epub 2020 Mar 20.
4
Separation of Acute Desensitization and Long-Term Tolerance of -Opioid Receptors Is Determined by the Degree of C-Terminal Phosphorylation.- 阿片受体的急性脱敏和长期耐受的分离取决于 C 端磷酸化程度。
Mol Pharmacol. 2019 Oct;96(4):505-514. doi: 10.1124/mol.119.117358. Epub 2019 Aug 5.
5
Cellular tolerance at the µ-opioid receptor is phosphorylation dependent.µ-阿片受体的细胞耐受依赖于磷酸化。
Elife. 2018 Mar 28;7:e34989. doi: 10.7554/eLife.34989.
6
PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway.PARK14 PLA2G6突变体在预防鱼藤酮诱导的线粒体功能障碍、活性氧生成及线粒体凋亡途径激活方面存在缺陷。
Oncotarget. 2017 Sep 15;8(45):79046-79060. doi: 10.18632/oncotarget.20893. eCollection 2017 Oct 3.
7
Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.脊髓或脊髓上的MOR C末端磷酸化缺陷不影响体内吗啡耐受性。
Pharmacol Res. 2017 May;119:153-168. doi: 10.1016/j.phrs.2017.01.033. Epub 2017 Feb 4.
8
Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.μ阿片受体的激动剂结合与脱敏受C末端尾域磷酸化的调节。
Mol Pharmacol. 2015 Oct;88(4):816-24. doi: 10.1124/mol.114.097527. Epub 2015 May 1.
9
Desensitization of functional µ-opioid receptors increases agonist off-rate.功能性μ阿片受体脱敏增加激动剂的失活速率。
Mol Pharmacol. 2014 Jul;86(1):52-61. doi: 10.1124/mol.114.092098. Epub 2014 Apr 18.
10
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.μ 型阿片受体的调节:脱敏、磷酸化、内化和耐受。
Pharmacol Rev. 2013 Jan 15;65(1):223-54. doi: 10.1124/pr.112.005942. Print 2013 Jan.